Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,299,366
-$2,443,946 QoQ
Shares Held
62,965
-61.2% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#144
of 423 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $21,876,011 across 22 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
48,590 | $3,491,677 | |
| 2 | ALKS |
Alkermes plc.
This page
|
62,965 | $3,299,366 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
18,743 | $3,158,945 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
5,742 | $3,111,187 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
265,618 | $2,656,180 | |
| 6 | VTRS |
Viatris Inc
|
140,790 | $2,235,745 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
152,878 | $643,616 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
16,555 | $407,418 |
All Filings in ALKS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,299,366 | 62,965 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,743,312 | 162,424 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,687,326 | 203,264 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,397,060 | 179,902 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,614,363 | 161,285 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,967,792 | 150,448 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,027,520 | 209,580 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,150,241 | 255,457 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,952,199 | 288,473 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,487,067 | 313,523 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,630,689 | 347,177 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $8,642,345 | 308,545 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,350,589 | 266,792 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,207,280 | 255,668 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,571,110 | 328,018 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,489,790 | 290,631 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,185,912 | 140,514 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,815,667 | 221,044 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,678,300 | 244,123 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,148,640 | 102,096 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,555,351 | 104,215 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,204,815 | 171,564 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $873,131 | 43,766 | Shares | Sole | 2021-02-10 | |
| 2020-06-30 | $1,133,214 | 58,383 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $244,260 | 16,939 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||